UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2376-2379

2013

Volltextzugriff (PDF)

Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis

Antimicrobial agents and chemotherapy, 2014-09, Vol.58 (9), p.5253-5261

2014

Volltextzugriff (PDF)

Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections

Antimicrobial agents and chemotherapy, 2019-11, Vol.63 (11)

2019

Volltextzugriff (PDF)

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria

Clinical microbiology and infection, 2006-03, Vol.12 (s1), p.24-32

Rybak, M.J.

2006

Volltextzugriff (PDF)

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.1062-1066

2000

Volltextzugriff (PDF)

Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity

Antimicrobial Agents and Chemotherapy, 1999-07, Vol.43 (7), p.1549-1555

1999

Volltextzugriff (PDF)

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation

European journal of clinical microbiology & infectious diseases, 2013-06, Vol.32 (6), p.815-820

2013

Volltextzugriff (PDF)

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations

Antimicrobial agents and chemotherapy, 2001-02, Vol.45 (2), p.454-459

2001

Volltextzugriff (PDF)

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2921-2926

2013

Volltextzugriff (PDF)

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

Antimicrobial Agents and Chemotherapy, 1996-03, Vol.40 (3), p.691-695

1996

Volltextzugriff (PDF)

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections

Antimicrobial Agents and Chemotherapy, 1996-03, Vol.40 (3), p.696-700

1996

Volltextzugriff (PDF)

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Antimicrobial Agents and Chemotherapy, 1998-03, Vol.42 (3), p.721-724

1998

Volltextzugriff (PDF)

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 1996-03, Vol.40 (3), p.677-683

1996

Volltextzugriff (PDF)

In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1925-1929

2000

Volltextzugriff (PDF)

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals

Journal of antimicrobial chemotherapy, 2009-11, Vol.64 (5), p.1024-1028

2009

Volltextzugriff (PDF)

Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus

Antimicrobial agents and chemotherapy, 1999-02, Vol.43 (2), p.335-340

1999

Volltextzugriff (PDF)

The Pharmacologic and Bacteriologic Properties of Oxazolidinones, a New Class of Synthetic Antimicrobials

Pharmacotherapy, 1998-05, Vol.18 (3), p.456-462

1998

Volltextzugriff (PDF)

Activities of Trovafloxacin, Gatifloxacin, Clinafloxacin, Sparfloxacin, Levofloxacin, and Ciprofloxacin against Penicillin-Resistant Streptococcus pneumoniae in an In Vitro Infection Model

Antimicrobial Agents and Chemotherapy, 2000-03, Vol.44 (3), p.598-601

2000

Volltextzugriff (PDF)

Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium

Antimicrobial Agents and Chemotherapy, 1997-06, Vol.41 (6), p.1307-1312

1997

Volltextzugriff (PDF)

Epidemiology, Resistance, and Outcomes of Acinetobacter baumannii Bacteremia Treated with Imipenem-Cilastatin or Ampicillin-Sulbactam

Pharmacotherapy, 2001-02, Vol.21 (2), p.142-148

2001

Volltextzugriff (PDF)

The Importance of Bactericidal Drugs: Future Directions in Infectious Disease

Clinical infectious diseases, 2004-11, Vol.39 (9), p.1314-1320

2004

Volltextzugriff (PDF)

Analysis of Vancomycin Population Susceptibility Profiles, Killing Activity, and Postantibiotic Effect against Vancomycin-Intermediate Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 1999-08, Vol.43 (8), p.1914-1918

1999

Volltextzugriff (PDF)

Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

Antimicrobial Agents and Chemotherapy, 2000-11, Vol.44 (11), p.2991-2998

2000

Volltextzugriff (PDF)

Activity of Oritavancin (LY333328), an Investigational Glycopeptide, Compared to That of Vancomycin against Multidrug-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2001-03, Vol.45 (3), p.706-709

2001

Volltextzugriff (PDF)

1 – 25 von 1.168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(993)
Mit Volltextzugriff
(928)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(637)
Life Sciences & Biomedicine
(541)
Humans
(452)
Biological And Medical Sciences
(251)
Pharmacology & Pharmacy
(232)
Medical Sciences
(221)
Microbiology
(197)
Female
(193)
Male
(187)
Pharmacology. Drug Treatments
(173)
Animals
(166)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(138)
Microbial Sensitivity Tests
(130)
Infectious Diseases
(129)
Adult
(117)
Middle Aged
(114)
Antibacterial Agents
(109)
Anti-Bacterial Agents - Pharmacology
(103)
Staphylococcus Aureus
(98)
Aged
(78)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis

Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains

Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals

Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus

The Pharmacologic and Bacteriologic Properties of Oxazolidinones, a New Class of Synthetic Antimicrobials

Activities of Trovafloxacin, Gatifloxacin, Clinafloxacin, Sparfloxacin, Levofloxacin, and Ciprofloxacin against Penicillin-Resistant Streptococcus pneumoniae in an In Vitro Infection Model

Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium

Epidemiology, Resistance, and Outcomes of Acinetobacter baumannii Bacteremia Treated with Imipenem-Cilastatin or Ampicillin-Sulbactam

The Importance of Bactericidal Drugs: Future Directions in Infectious Disease

Analysis of Vancomycin Population Susceptibility Profiles, Killing Activity, and Postantibiotic Effect against Vancomycin-Intermediate Staphylococcus aureus

Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

Activity of Oritavancin (LY333328), an Investigational Glycopeptide, Compared to That of Vancomycin against Multidrug-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model

Suchergebnisse filtern